Format

Send to

Choose Destination
See comment in PubMed Commons below
N Engl J Med. 2014 Feb 27;370(9):794-7. doi: 10.1056/NEJMp1314078.

Pancreatic safety of incretin-based drugs--FDA and EMA assessment.

Author information

1
From the Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD (A.G.E., B.T.H., T.B., C.R.); the European Medicines Agency, London (E.B.); Läkemedelsverket, Uppsala, Sweden (K.D.); and the Dutch Medicines Evaluation Board, Utrecht, the Netherlands (P.A.G.).

Erratum in

  • N Engl J Med. 2014 Jun 5;370(23):2253.
PMID:
24571751
DOI:
10.1056/NEJMp1314078
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Support Center